These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26426060)

  • 1. Micelle-Based Adjuvants for Subunit Vaccine Delivery.
    Trimaille T; Verrier B
    Vaccines (Basel); 2015 Sep; 3(4):803-13. PubMed ID: 26426060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled amphiphilic copolymers as dual delivery system for immunotherapy.
    Trimaille T; Lacroix C; Verrier B
    Eur J Pharm Biopharm; 2019 Sep; 142():232-239. PubMed ID: 31229673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy.
    Luo Z; Li P; Deng J; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Sep; 170(2):259-67. PubMed ID: 23742880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentablock Copolymer Micelle Nanoadjuvants Enhance Cytosolic Delivery of Antigen and Improve Vaccine Efficacy while Inducing Low Inflammation.
    Senapati S; Darling RJ; Loh D; Schneider IC; Wannemuehler MJ; Narasimhan B; Mallapragada SK
    ACS Biomater Sci Eng; 2019 Mar; 5(3):1332-1342. PubMed ID: 33405651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.
    Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S
    ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Delivery Method and Nanoparticle Charge Influence Peptide Amphiphile Micelle Vaccine Bioactivity.
    Zhang R; Rygelski BT; Kruse LE; Smith JD; Wang X; Allen BN; Kramer JS; Seim GF; Faulkner TJ; Kuang H; Kokkoli E; Schrum AG; Ulery BD
    bioRxiv; 2024 Oct; ():. PubMed ID: 38915689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
    Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X
    Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Wonders-The Use of Nanoparticles for Delivering Antigen.
    Taki A; Smooker P
    Vaccines (Basel); 2015 Aug; 3(3):638-61. PubMed ID: 26350599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.
    Foged C
    Ther Deliv; 2011 Aug; 2(8):1057-77. PubMed ID: 22826868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
    Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
    AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica Nanoparticle as a Lymph Node Targeting Platform for Vaccine Delivery.
    An M; Li M; Xi J; Liu H
    ACS Appl Mater Interfaces; 2017 Jul; 9(28):23466-23475. PubMed ID: 28640587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination.
    Trent A; Ulery BD; Black MJ; Barrett JC; Liang S; Kostenko Y; David NA; Tirrell MV
    AAPS J; 2015 Mar; 17(2):380-8. PubMed ID: 25527256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.
    Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D
    Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus.
    Barrett JC; Ulery BD; Trent A; Liang S; David NA; Tirrell MV
    ACS Biomater Sci Eng; 2017; 3(2):144-152. PubMed ID: 29242824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
    Moyle PM
    Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in vaccine delivery systems.
    O'Hagan DT
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy.
    Yu R; Mai Y; Zhao Y; Hou Y; Liu Y; Yang J
    J Drug Target; 2019 Aug; 27(7):780-789. PubMed ID: 30589361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of polymeric nanoparticles-based vaccine].
    Akagi T; Akashi M
    Nihon Rinsho; 2006 Feb; 64(2):279-85. PubMed ID: 16454182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic solvent-free low temperature method of preparation for self assembled amphiphilic poly(ϵ-caprolactone)-poly(ethylene glycol) block copolymer based nanocarriers for protein delivery.
    Payyappilly SS; Panja S; Mandal P; Dhara S; Chattopadhyay S
    Colloids Surf B Biointerfaces; 2015 Nov; 135():510-517. PubMed ID: 26291587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.